CAR-T manufacture ‘where mAbs were in the early 1990s’, says bluebird CTMO
With cell and gene therapies developing at a rapid pace, it leaves significant questions as to how manufacturing processes are keeping up.
With cell and gene therapies developing at a rapid pace, it leaves significant questions as to how manufacturing processes are keeping up.